share_log

Morgan Stanley Initiates Coverage On Mural Oncology With Overweight Rating, Announces Price Target of $13

Morgan Stanley Initiates Coverage On Mural Oncology With Overweight Rating, Announces Price Target of $13

摩根士丹利以增持評級啓動對壁畫腫瘤學的報道,宣佈目標股價爲13美元
Moomoo 24/7 ·  04/04 06:39

Morgan Stanley analyst Judah Frommer initiates coverage on Mural Oncology (NASDAQ:MURA) with a Overweight rating and announces Price Target of $13.

摩根士丹利分析師猶大·弗羅默以增持評級啓動了對Mural Oncology(納斯達克股票代碼:MURA)的報道,並宣佈目標股價爲13美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論